117 Publications (Page 3 of 5)
2011
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002).
Bashey, Asad⋅Owzar, Kouros⋅Johnson, Jeffrey L⋅Edwards, Peggy S⋅Kelly, Michael⋅Baxter Lowe, Lee A⋅Devine, Steven⋅Farag, Sherif⋅Hurd, David⋅Ball, Edward D⋅Mc Carthy, Philip⋅Lister, John⋅Shea, Thomas C and Linker, Charles
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 17, (no. 4), pp. 558-65, 2011/Apr. | Journal Article
 
The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells
Zhang, Shuhong⋅Zhang, Shuhong⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin D⋅Crean, Colin D⋅White, Valerie L⋅White, Valerie L⋅Chen, Ching‐Shih⋅Chen, Ching Shih⋅Farag, Sherif S and Farag, Sherif S
International Journal of Cancer, vol. 129, (no. 1), pp. 204-213, 2011. | Journal Article
 
The potential role of Aurora kinase inhibitors in haematological malignancies.
Farag, Sherif S
British journal of haematology, vol. 155, (no. 5), pp. 561-79, 2011/Dec. | Journal Article
2010
Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.
Nelson, Robert P⋅Yu, Menggang⋅Schwartz, Jennifer⋅Robertson, Michael J⋅Hromas, Robert A⋅Fausel, C A⋅Vance, Gail H⋅Dlouhy, Stephen R⋅Baute, J A⋅Cox, E A⋅Wood, L L⋅Srivastava, Shivani⋅Robertson, Kent⋅Haut, P R⋅Farag, Sherif S⋅Abonour, Rafat⋅Cornetta, Kenneth G and Cripe, Larry D
Bone marrow transplantation, vol. 45, (no. 8), pp. 1300-8, 2010/Aug. | Journal Article
 
Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma
Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Sinn, Anthony⋅Sinn, Anthony L⋅Sinn, Anthony⋅Sinn, Anthony⋅Pollok, Karen⋅Pollok, Karen⋅Pollok, Karen⋅Pollok, Karen⋅Sandusky, George⋅Sandusky, George⋅Sandusky, George⋅Sandusky, George⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Crean, Colin D⋅Crean, Colin⋅Crean, Colin⋅Crean, Colin⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Bray, Mark⋅Bray, Mark R⋅Bray, Mark⋅Bray, Mark⋅Farag, Sherif⋅Farag, Sherif⋅Farag, Sherif and Farag, Sherif S
British Journal of Haematology, vol. 150, (no. 3), pp. 313-325, 2010. | Journal Article
 
Quantification of non-specific binding of magnetic micro- and nanoparticles using cell tracking velocimetry: Implication for magnetic cell separation and detection
Chalmers, Jeffrey John⋅Xiong, Y.⋅Jin, X.⋅Shao, M.⋅Tong, X.⋅Farag, S. and Zborowski, Maciej
Biotechnology and Bioengineering, vol. 105, (no. 6), Apr 15, 2010. | Journal Article
2009
Natural killer cell activity and killer immunoglobulin-like receptors in hematopoietic stem cell transplantation.
Ruggeri, Loredana⋅Ruggeri, Loredana⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Farag, Sherif S and Farag, Sherif S
Cancer treatment and research, vol. 144, pp. 47-69, 2009. | Journal Article
 
Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma
Farag, Sherif S⋅Farag, Sherif⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Jansak, Buffy S⋅Jansak, Buffy⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Kraut, Eric H⋅Kraut, Eric⋅Chan, Kenneth K⋅Chan, Kenneth⋅Dancey, Janet E⋅Dancey, Janet⋅Grever, Michael and Grever, Michael R
Leukemia Research, vol. 33, (no. 11), pp. 1475-1480, 2009. | Journal Article
 
Phase I Trial of Lenalidomide and CCI-779 in Patients with Relapsed Multiple Myeloma
Hofmeister, Craig C⋅Benson, Don⋅Efebera, Yvonne A⋅Farag, Sherif and Grever, Michael R
Blood, vol. 114, (no. 22), pp. 2884, 2009-11-20. | Journal Article
2008
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.
Hamadani, Sayed M⋅Hofmeister, Craig C⋅Jansak, Buffy⋅Phillips, Gary⋅Elder, Patrick⋅Blum, William⋅Penza, Sam L⋅Lin, Thomas S⋅Klisovic, Rebecca⋅Marcucci, Guido⋅Farag, Sherif S and Devine, Steven M
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 14, (no. 7), pp. 783-9, 2008/Jul. | Journal Article
 
Antimyeloma Effects of a Sesquiterpene Lactone Parthenolide
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin⋅Crean, Colin D⋅Crean, Colin⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Farag, Sherif⋅Farag, Sherif S⋅Farag, Sherif⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Boswell, H.⋅Boswell, HScott⋅Boswell, H.⋅Nakshatri, Harikrishna⋅Nakshatri, Harikrishna and Nakshatri, Harikrishna
Clinical Cancer Research, vol. 14, (no. 6), pp. 1814-1822, 2008. | Journal Article
 
Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma
Hofmeister, Craig C⋅Jansak, B.⋅Denlinger, N.⋅Kraut, Eric H⋅Benson, Don M and Farag, Sherif S
Leukemia Research, vol. 32, (no. 8), pp. 1295-1298, 2008. | Journal Article
 
Synergistic Activity of Bendamustine in Combination with Doxorubicin and Bortezomib in Multiple Myeloma Cells
Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S and Farag, Sherif S
Blood, vol. 112, (no. 11), pp. 5171, 2008-11-16. | Journal Article
 
The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo, and Shows Synergistic Activity in Combination with Lenalidomide
Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Zhang, Genglin⋅Zhang, Genglin⋅Zhang, Genglin⋅Zhang, Genglin⋅Zhang, Genglin⋅Zhang, Genglin⋅Pollok, Karen E⋅Pollok, Karen E⋅Pollok, Karen E⋅Pollok, Karen E⋅Pollok, Karen E⋅Pollok, Karen E⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Bray, Mark R⋅Bray, Mark R⋅Bray, Mark R⋅Bray, Mark R⋅Bray, Mark R⋅Bray, Mark R⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S and Farag, Sherif S
Blood, vol. 112, (no. 11), pp. 3660, 2008-11-16. | Journal Article
2007
A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation.
Tong, Xiaodong⋅Xiong, Ying⋅Zborowski, Maciej⋅Farag, Sherif S and Chalmers, Jeffrey John
Experimental hematology, vol. 35, (no. 10), pp. 1613-22, 2007/Oct. | Journal Article
 
Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis
Jing, Ying⋅Jing, Ying⋅Moore, Lee R⋅Moore, Lee R⋅Williams, P. Stephen⋅Williams, P. S⋅Chalmers, Jeffrey J⋅Chalmers, Jeffrey John⋅Farag, Sherif S⋅Farag, Sherif S⋅Bolwell, Brian⋅Bolwell, Brian⋅Zborowski, Maciej and Zborowski, Maciej
Biotechnology and Bioengineering, vol. 96, (no. 6), pp. 1154, 15 April 2007. | Journal Article
 
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma
Benson, Don M⋅Elder, Patrick J⋅Lin, Thomas S⋅Blum, William⋅Penza, Sam L⋅Avalos, Belinda R⋅Copelan, Edward A and Farag, Sherif S
Leukemia Research, vol. 31, (no. 8), pp. 1069-1075, 2007. | Journal Article
 
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.
Miller, Jeffery S⋅Miller, J.S.⋅Cooley, S.⋅Cooley, Sarah A⋅Parham, Peter⋅Parham, P.⋅Farag, S.S.⋅Farag, Sherif S⋅Verneris, M.R.⋅Verneris, Michael R⋅McQueen, K.L.⋅McQueen, Karina L⋅Guethlein, Lisbeth A⋅Guethlein, L.A.⋅Trachtenberg, E.A.⋅Trachtenberg, Elizabeth A⋅Haagenson, Michael⋅Haagenson, M.⋅Horowitz, Mary M⋅Horowitz, M.M.⋅Klein, John P⋅Klein, J.P.⋅Weisdorf, D.J. and Weisdorf, Dan
Blood, vol. 109, (no. 11), pp. 5058-61, 2007/Jun/1. | Journal Article
 
Multiple myeloma. Clinical practice guidelines in oncology
Anderson, Kenneth C⋅Anderson, Kenneth C⋅Anderson, Kenneth C⋅Alsina, Melissa⋅Alsina, Melissa⋅Alsina, Melissa⋅Bensinger, William⋅Bensinger, William⋅Bensinger, William⋅Biermann, J S⋅Biermann, J Sybil⋅Biermann, J Sybil⋅Chanan-Khan, Asher⋅Chanan-Khan, Asher⋅Chanan-Khan, Asher⋅Comenzo, Raymond L⋅Comenzo, Raymond L⋅Comenzo, Raymond L⋅De Castro, Carlos M⋅De Castro, Carlos M⋅De Castro, Carlos M⋅Djulbegovic, Benjamin⋅Djulbegovic, Benjamin⋅Djulbegovic, Benjamin⋅Farag, Sherif⋅Farag, Sherif⋅Farag, Sherif⋅Huff, Carol Ann⋅Huff, Carol A⋅Huff, Carol Ann⋅Meredith, Ruby⋅Meredith, Ruby⋅Meredith, Ruby⋅Schriber, Jeffrey⋅Schriber, Jeffrey⋅Schriber, Jeffrey⋅Shrieve, Dennis⋅Shrieve, Dennis⋅Shrieve, Dennis⋅Singhal, Seema⋅Singhal, Seema⋅Singhal, Seema⋅Smith, Mitchell R⋅Smith, Mitchell R⋅Smith, Mitchell R⋅Stockerl Goldstein, Keith E⋅Stockerl-Goldstein, Keith⋅Stockerl-Goldstein, Keith⋅Vose, Julie M⋅Vose, Julie M⋅Vose, Julie M⋅Weber, Donna⋅Weber, Donna⋅Weber, Donna⋅Yahalom, Joachim⋅Yahalom, Joachim⋅Yahalom, Joachim⋅Yunus, Furhan⋅Yunus, Furhan and Yunus, Furhan
Journal of the National Comprehensive Cancer Network : JNCCN, vol. 5, (no. 2), pp. 118, 2007-Feb. | Journal Article
 
Negative selection of hematopoietic progenitor cells by continuous magnetophoresis
Jing, Ying⋅Jing, Ying⋅Moore, Lee R⋅Moore, Lee⋅Schneider, Thomas⋅Schneider, Thomas⋅Williams, P. S⋅Williams, P.⋅Chalmers, Jeffrey⋅Chalmers, Jeffrey John⋅Farag, Sherif⋅Farag, Sherif S⋅Bolwell, Brian⋅Bolwell, Brian⋅Zborowski, Maciej and Zborowski, Maciej
Experimental Hematology, vol. 35, (no. 4), pp. 672, 2007. | Journal Article
 
OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin D⋅Crean, Colin⋅Crean, Colin⋅White, Valerie L⋅White, Valerie⋅White, Valerie⋅Johnson, Amy⋅Johnson, Amy⋅Johnson, Amy⋅Chen, Ching-Shih⋅Chen, Ching-Shih⋅Chen, Ching Shih⋅Farag, Sherif⋅Farag, Sherif S and Farag, Sherif
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 13, (no. 16), pp. 4750-8, 2007/Aug/15. | Journal Article
 
Unlike Inactivating PTEN Mutations, Pharmacological Inhibition of PTEN Does Not Increase the Sensitivity of Multiple Myeloma Cells to Inhibition of the PI3K/Akt/mTOR Pathway
Wang, Xiaojing⋅Wang, Xiaojing⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Peng, Xiaodong⋅Peng, Xiaodong⋅Garlich, Joe⋅Garlich, Joe⋅Chen, Li⋅Chen, Li⋅Liang, Jing⋅Liang, Jing⋅Farag, Sherif Shafik and Farag, Sherif Shafik
Blood, vol. 110, (no. 11), pp. 4785, 2007-11-16. | Journal Article
2006
Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples
Lara, Oscar⋅Lara, Oscar⋅Tong, Xiaodong⋅Tong, Xiaodong⋅Zborowski, Maciej⋅Zborowski, Maciej⋅Farag, Sherif S⋅Farag, Sherif S⋅Chalmers, Jeffrey J and Chalmers, Jeffrey John
Biotechnology and Bioengineering, vol. 94, (no. 1), pp. 80, 5 May 2006. | Journal Article
 
High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.
Blum, William⋅Bolwell, Brian J⋅Phillips, Gary⋅Farag, Sherif S⋅Lin, Thomas S⋅Avalos, Belinda R⋅Penza, Sam L⋅Marcucci, Guido⋅Byrd, John C⋅Kalaycio, Matt E⋅Sobecks, Ronald M⋅Pohlman, Brad⋅Brown, Stacey⋅Elder, Patrick J and Copelan, Edward A
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 12, (no. 1), pp. 61-7, 2006/Jan. | Journal Article
 
Human natural killer cell development and biology.
Farag, Sherif S and Caligiuri, Michael A
Blood reviews, vol. 20, (no. 3), pp. 123-37, 2006/May. | Journal Article